| Jordan Cameron, DPM | |
|
1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920-3945 | |
| (719) 488-4664 | |
| (719) 488-4667 |
| Full Name | Jordan Cameron |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 11 Years |
| Location | 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578995809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | POD786 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foot And Ankle Institute Of Colorado Pc | 5395066013 | 3 |
News Archive
A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.
Fenfluramine, the appetite suppressant drug banned in the US in 1997 due to fears over its links to heart conditions, has been shown to have serious long-term effects.
Scientists at the University of North Carolina at Chapel Hill have developed a breakthrough technique that uses light to activate a drug stored in circulating red blood cells so that it is released exactly when and where it is needed.
University of Delaware professor Xinqiao Jia is part of a research team breaking new ground in the creation of artificial salivary glands.
› Verified 2 days ago
| Provider Name | Foot And Ankle Institute Of Colorado Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003294083 PECOS PAC ID: 5395066013 Enrollment ID: O20150608000140 |
News Archive
A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.
Fenfluramine, the appetite suppressant drug banned in the US in 1997 due to fears over its links to heart conditions, has been shown to have serious long-term effects.
Scientists at the University of North Carolina at Chapel Hill have developed a breakthrough technique that uses light to activate a drug stored in circulating red blood cells so that it is released exactly when and where it is needed.
University of Delaware professor Xinqiao Jia is part of a research team breaking new ground in the creation of artificial salivary glands.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan Cameron, DPM 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920-3945 Ph: (719) 488-4664 | Jordan Cameron, DPM 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920-3945 Ph: (719) 488-4664 |
News Archive
A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.
Fenfluramine, the appetite suppressant drug banned in the US in 1997 due to fears over its links to heart conditions, has been shown to have serious long-term effects.
Scientists at the University of North Carolina at Chapel Hill have developed a breakthrough technique that uses light to activate a drug stored in circulating red blood cells so that it is released exactly when and where it is needed.
University of Delaware professor Xinqiao Jia is part of a research team breaking new ground in the creation of artificial salivary glands.
› Verified 2 days ago
Dr. Matthew Diehl Hinderland, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920 Phone: 719-488-4664 Fax: 719-488-4667 | |
Foot And Ankle Institute Of Colorado, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920 Phone: 719-488-4664 Fax: 719-488-4667 | |
Mcvay Foot & Ankle, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 6160 Tutt Blvd, Ste 150, Colorado Springs, CO 80923 Phone: 719-266-5000 Fax: 719-266-6596 | |
Dr. Tim Carlsen, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2620 Tenderfoot Hill St, Suite 10, Colorado Springs, CO 80906 Phone: 719-576-2080 Fax: 719-576-2248 | |
Candice Cooper, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8580 Scarborough Dr Ste 120, Colorado Springs, CO 80920 Phone: 719-266-5000 Fax: 719-266-6596 | |
Dr. Matthew Reed Thomas, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2620 Tenderfoot Hill St Ste 200, Colorado Springs, CO 80906 Phone: 719-867-8838 | |
Dr. Trevor Keith Whiting, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1465 Kelly Johnson Blvd Ste 100, Colorado Springs, CO 80920 Phone: 719-488-4664 Fax: 719-488-4667 |